ホルモン補充療法市場- 世界の産業規模、シェア、動向、競合、機会、予測、2018年～2028年

世界のホルモン補充療法（HRT）市場は、2024年から2028年の予測期間中に高いCAGRで上昇すると予想されています。

世界のさまざまな発展途上国の人々の間で一般的である他のホルモン不均衡障害の有病率の増加は、予測期間中に世界のホルモン補充療法市場に有利な成長を記録すると予想されます。世界の老人人口の増加と、高齢期の人々に関連するアンドロポーズ、甲状腺機能亢進症、甲状腺機能低下症などの特定のホルモン疾患は、予測期間中に世界中のホルモン補充療法市場の成長を促進すると期待されています。さらに、ホルモン補充療法の技術革新につながる世界のヘルスケアインフラの改善は、予測期間中に世界のホルモン補充療法市場に目覚ましい成長を記録することがさらに期待されています。

調査範囲

本レポートでは、世界のホルモン補充療法市場を以下のカテゴリーに分類し、さらに業界動向についても詳述しています。

ホルモン補充療法市場、製品別

• エストロゲンおよびプロゲステロン補充療法
• HGH補充療法
• 甲状腺ホルモン補充療法
• 男性ホルモン補充療法
• 副甲状腺ホルモン補充療法

ホルモン補充療法市場：投与経路別

• 経口
• 非経口
• 経皮
• その他

ホルモン補充療法市場：疾患タイプ別

• 更年期障害
• 甲状腺機能低下症
• 男性性腺機能低下症
• 成長ホルモン欠乏症
• 副甲状腺機能低下症

ホルモン補充療法の世界市場：地域別

• 北米
• 米国
• カナダ
• メキシコ
• アジア太平洋
• 中国
• インド
• 韓国
• オーストラリア
• 日本
• 欧州
• ドイツ
• フランス
• 英国
• スペイン
• イタリア
• 南米
• ブラジル
• アルゼンチン
• コロンビア
• 中東＆アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

競合情勢

• 企業プロファイル：ホルモン補充療法の世界市場における主要企業の詳細分析

利用可能なカスタマイズ：

• TechSci Research社は、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です：

企業情報

• 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 ホルモン補充療法の世界市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別（エストロゲン＆プロゲステロン補充療法、HGH補充療法、甲状腺ホルモン補充療法、テストステロン補充療法、副甲状腺ホルモン補充療法）
  • 投与経路別（経口、非経口、経皮、その他）
  • 疾患タイプ別（更年期障害、甲状腺機能低下症、男性性腺機能低下症、成長ホルモン欠乏症、副甲状腺機能低下症）
  • 地域別
  • 企業別（2022年）
• 製品市場マップ

第6章 北米ホルモン補充療法市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別
  • 投与経路別
  • 疾患タイプ別
  • 国別
• 北米国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州ホルモン補充療法市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別
  • 投与経路別
  • 疾患タイプ別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のホルモン補充療法市場展望

• 市場規模および予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別
  • 投与経路別
  • 疾患タイプ別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米ホルモン補充療法市場の展望

• 市場規模および予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別
  • 投与経路別
  • 疾患タイプ別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカホルモン補充療法市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別
  • 投与経路別
  • 疾患タイプ別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

第13章 PESTLE分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Business Overview
• Company Snapshot
• Products & Services
• Financials（In case of listed companies）
• Recent Developments
• SWOT Analysis
  • Bayer AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • TherapeuticsMD, Inc.
  • Novo Nordisk A/S
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.（Genentech）
  • Hisamitsu Pharmaceutical Co., Inc.（Noven Pharmaceuticals, Inc.）
  • ASCEND Therapeutics US, LLC.（Besins Healthcare）
  • Halozyme Therapeutics, Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global hormone replacement therapy (HRT) market is expected to rise at a high CAGR during the forecast period, 2024-2028. Growing prevalence of other hormonal imbalance disorders which are common among people of various developing countries in the world are expected to register a lucrative growth to global hormone replacement therapy market in the forecast period. Growth in global geriatric population and certain hormonal disorders such as andropause, hyperthyroidism, hypothyroidism, and others which are associated with people during their elder age are expected to propel the growth of hormone replacement therapy market across the world in the forecast period. Furthermore, improvement in worldwide healthcare infrastructure which are leading to innovations in hormone replacement therapy are further expected to register an impressive growth to global hormone replacement therapy market in the forecast period.

Hormone Replacement Therapy (HRT) is a medical treatment that involves replacing the hormones that are produced in lower quantities in the body especially after treatment of certain types of cancer and menopause in women. Various types of hormone replacement therapy that are commonly performed across the world includes estrogen-only therapy, combination therapy, transdermal therapy, and bioidentical hormone therapy.

The United States of America, Canada, Australia, and several European countries such as France, Italy, and Sweden account for highest number of hormone replacement therapies performed among their population in the forecast period. Several health conditions that can be efficiently managed by hormone replacement therapy in the human body comprise of menopause symptoms, osteoporosis, hypogonadism, gender dysphoria, endometriosis, and breast cancer.

Rising Prevalence of Hormonal Imbalance Disorders

Hormonal imbalance disorders can be referred to development of certain health conditions which are caused by abnormality in the production, regulation, and function of hormones in the human body. Some of the hormonal imbalance disorders which can affect both men and women includes polycystic ovary syndrome (PCOS), thyroid disorders, adrenal disorders, pituitary gland disorders, reproductive disorders, parathyroid disorders, and others. Major risk factors which can lead to development of hormonal imbalances in a person include genetic predisposition, age, lifestyle choices, medical conditions, and environmental changes.

Among various hormonal disorders, polycystic ovary syndrome (PCOS) is one of the most prevalent hormonal disorders affecting women of reproductive age. It is estimated that PCOS affects 5-10% of women of reproductive age worldwide. South Asia, Middle East, and North Africa are some of the regions which account for highest number of PCOS cases in recent years. According to the report published by BMC on Reproductive Biology and Endocrinology in 2021, it has been observed that India stood at highest position for around 22.7% PCOS cases being diagnosed in the country, followed by 20% cases in Philippines, 15.9% cases in Australia, 13.7% cases in United Kingdom, 12.2% cases in United States of America, and so on.

Hormone Replacement Therapy involves taking synthetic hormones to replace the hormones that are not being produced adequately by the body. In case of polycystic ovary syndrome (PCOS), hormone replacement therapy is used to regulate menstrual cycles, reduce hair growth, and remove acne. Another common hormonal disorders which are prevailing people of every age group and gender worldwide are thyroid disorders such as hypothyroidism and hyperthyroidism. According to World Health Organization (WHO), around 750 million people are suffering from some form of thyroid disorder in the world. The prevalence of thyroid disorders increases with age which account for around 20% women over 60 years of age having some form of thyroid dysfunction. In some regions, such as Southeast Asia, Africa, and South America around 50% of people are diagnosed with iodine deficiency every year which leads to the development of goiter (enlarged thyroid gland) and hypothyroidism. Moreover, effective results in management of various hormonal disorders after hormone replacement therapy are expected to register an impressive growth of global hormone replacement therapy market in the forecast period.

Growth in Geriatric Population

With increase in age, people tend to develop more symptoms of various hormonal imbalance disorders in their body. Some of the most common hormonal imbalances which affect people during their elder age include menopause, hypothyroidism, andropause, adrenal insufficiency, and diabetes. Among various hormonal disorders, menopause accounts for highest number of instances across various developing countries of the world. According to Menopause Foundation of Canada, by 2025, more than 1 billion women in the world will be experiencing menopause. Various kind of symptoms which are experienced by people during menopause comprise of hot flushes, vaginal dryness, night sweats, weight gain, and others. According to the report published by Forth with Life in 2019, it has been observed that around 73% of people suffer from hot flushes during menopause followed by 63% of people suffering from drowsiness, 47% people from low concentration, 43% people from memory troubles, and so on. Moreover, growth in worldwide geriatric population and rise in certain hormonal imbalances which are associated with people during their elder age are further expected to register a lucrative growth to global hormone replacement therapy market in the forecast period. According to the report published by Population Reference Bureau (PRB) based on countries with the oldest populations in the world, it has been concluded that Japan is the foremost country in the world accounting for around 28.2% of geriatric people out of total population, followed by Italy with 22.8% of geriatric population, Greece, and Portugal with 21.8 %, and Germany with 21.4% of geriatric people out of the total population.

Development of Healthcare Infrastructure

Improvement in medical facilities provided by various hospitals and medical centers around the world is one of the significant factors which is expected to propel the growth of global hormone replacement therapy market in the forecast period. Moreover, establishment of various healthcare associations around the world along with availability of skilled healthcare professionals are allowing more people to undergo hormone replacement therapy in their individual countries which is thereby driving the growth of the market.

Market Segmentation

Global hormone replacement therapy market is segmented based on product, route of administration, disease type, company, and region. In terms of product, the global hormone replacement therapy market is categorized into estrogen and progesterone replacement therapy, HGH replacement therapy, thyroid hormone replacement therapy, testosterone replacement therapy, and parathyroid hormone replacement. Based on, route of administration, the global hormone replacement therapy market is segmented into oral, parenteral, transdermal, and others. Based on disease type, the market is segmented into menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, and hypoparathyroidism.

Market Players

Bayer AG, Pfizer Inc., Merck & Co., Inc., Viatris Inc., Novo Nordisk A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. (Genentech), Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.), ASCEND Therapeutics US, LLC. (Besins Healthcare), and AbbVie Inc.

Report Scope:

In this report, Global Hormone Replacement Therapy Market has been segmented into following categories, in addition to the industry trends which have also been detailed below.

Hormone Replacement Therapy Market, By Product:

• Estrogen and Progesterone Replacement Therapy
• HGH replacement therapy
• Thyroid hormone replacement therapy
• Testosterone Replacement Therapy
• Parathyroid Hormone replacement

Hormone Replacement Therapy Market, By Route of Administration:

• Oral
• Parenteral
• Transdermal
• Others

Hormone Replacement Therapy Market, By Disease Type:

• Menopause
• Hypothyroidism
• Male hypogonadism
• Growth hormone deficiency
• Hypoparathyroidism

Global Hormone Replacement Therapy Market, By region:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• South Korea
• Australia
• Japan
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in Global Hormone Replacement Therapy Market

Available Customizations:

• With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hormone Replacement Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value & Volume
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Estrogen & Progesterone Replacement Therapy, HGH replacement therapy, Thyroid hormone replacement therapy, Testosterone Replacement Therapy, and Parathyroid Hormone replacement)
  • 5.2.2. By Route of Administration (Oral, Parenteral, Transdermal, and Others)
  • 5.2.3. By Disease Type (Menopause, Hypothyroidism, Male hypogonadism, Growth hormone deficiency, and Hypoparathyroidism)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Product Market Map

6. North America Hormone Replacement Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value & Volume
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Route of Administration
  • 6.2.3. By Disease Type
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hormone Replacement Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value & Volume
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Route of Administration
      • 6.3.1.2.3. By Disease Type
  • 6.3.2. Mexico Hormone Replacement Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value & Volume
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Route of Administration
      • 6.3.2.2.3. By Disease Type
  • 6.3.3. Canada Hormone Replacement Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value & Volume
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Route of Administration
      • 6.3.3.2.3. By Disease Type

7. Europe Hormone Replacement Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value & Volume
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Route of Administration
  • 7.2.3. By Disease Type
  • 7.2.4. By Country
• 7.3 Europe: Country Analysis
  • 7.3.1. France Hormone Replacement Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value & Volume
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Route of Administration
      • 7.3.1.2.3. By Disease Type
  • 7.3.2. Germany Hormone Replacement Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value & Volume
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Route of Administration
      • 7.3.2.2.3. By Disease Type
  • 7.3.3. United Kingdom Hormone Replacement Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value & Volume
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Route of Administration
      • 7.3.3.2.3. By Disease Type
  • 7.3.4. Italy Hormone Replacement Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value & Volume
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Route of Administration
      • 7.3.4.2.3. By Disease Type
  • 7.3.5. Spain Hormone Replacement Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value & Volume
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Route of Administration
      • 7.3.5.2.3. By Disease Type

8. Asia-Pacific Hormone Replacement Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value & Volume
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Route of Administration
  • 8.2.3. By Disease Type
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Hormone Replacement Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value & Volume
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Route of Administration
      • 8.3.1.2.3. By Disease Type
  • 8.3.2. India Hormone Replacement Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value & Volume
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Route of Administration
      • 8.3.2.2.3. By Disease Type
  • 8.3.3. South Korea Hormone Replacement Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value & Volume
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Route of Administration
      • 8.3.3.2.3. By Disease Type
  • 8.3.4. Japan Hormone Replacement Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value & Volume
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Route of Administration
      • 8.3.4.2.3. By Disease Type
  • 8.3.5. Australia Hormone Replacement Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value & Volume
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Route of Administration
      • 8.3.5.2.3. By Disease Type

9. South America Hormone Replacement Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value & Volume
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Route of Administration
  • 9.2.3. By Disease Type
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Hormone Replacement Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value & Volume
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Route of Administration
      • 9.3.1.2.3. By Disease Type
  • 9.3.2. Argentina Hormone Replacement Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value & Volume
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Route of Administration
      • 9.3.2.2.3. By Disease Type
  • 9.3.3. Colombia Hormone Replacement Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value & Volume
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Route of Administration
      • 9.3.3.2.3. By Disease Type

10. Middle East and Africa Hormone Replacement Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value & Volume
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Route of Administration
  • 10.2.3. By Disease Type
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Hormone Replacement Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value & Volume
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Route of Administration
      • 10.3.1.2.3. By Disease Type
  • 10.3.2. Saudi Arabia Hormone Replacement Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value & Volume
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Route of Administration
      • 10.3.2.2.3. By Disease Type
  • 10.3.3. UAE Hormone Replacement Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value & Volume
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Route of Administration
      • 10.3.3.2.3. By Disease Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Company Snapshot
• 15.3. Products & Services
• 15.4. Financials (In case of listed companies)
• 15.5. Recent Developments
• 15.6. SWOT Analysis
  • 15.6.1. Bayer AG
  • 15.6.2. Pfizer Inc.
  • 15.6.3. Merck & Co., Inc.
  • 15.6.4. TherapeuticsMD, Inc.
  • 15.6.5. Novo Nordisk A/S
  • 15.6.6. AbbVie Inc.
  • 15.6.7. F. Hoffmann-La Roche Ltd. (Genentech)
  • 15.6.8. Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
  • 15.6.9. ASCEND Therapeutics US, LLC. (Besins Healthcare)
  • 15.6.10. Halozyme Therapeutics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer